For an adult outpatient with uncomplicated community‑acquired pneumonia who cannot use a macrolide (e.g., due to contraindication or intolerance), what is the appropriate cefixime plus doxycycline regimen, including dosing, duration, and renal dose adjustments?

Cefixime Plus Doxycycline for Community-Acquired Pneumonia

This Regimen Is Not Guideline-Concordant for Pneumonia

Cefixime plus doxycycline is not a recommended combination for community-acquired pneumonia in any major guideline, and cefixime specifically lacks adequate pneumococcal coverage for respiratory infections. 1, 2, 3

---

Why Cefixime Is Inappropriate for Pneumonia

• Cefixime demonstrates inferior in-vitro activity against Streptococcus pneumoniae compared to high-dose amoxicillin or ceftriaxone, the pathogens responsible for 48% of identified CAP cases, and is not listed as an acceptable oral cephalosporin in any pneumonia guideline. 1, 2

• The 2019 IDSA/ATS guidelines explicitly recommend only cefpodoxime or cefuroxime as acceptable oral cephalosporins for CAP, and even these agents are inferior to high-dose amoxicillin and should only be used when amoxicillin is contraindicated. 1, 2, 3

• Cefixime is classified as a third-generation cephalosporin designed primarily for urinary and gastrointestinal infections, not respiratory pathogens, and achieves suboptimal lung tissue concentrations. 2

---

Guideline-Concordant Alternatives When Macrolides Are Contraindicated

For Outpatients Without Comorbidities

• Amoxicillin 1 g orally three times daily for 5–7 days is the preferred first-line agent, providing activity against 90–95% of S. pneumoniae strains including many penicillin-resistant isolates. 1, 2, 3

• Doxycycline 100 mg orally twice daily for 5–7 days is the preferred alternative, offering broad-spectrum coverage of both typical and atypical pathogens with a conditional recommendation and low-quality evidence. 1, 2, 4

• A loading dose of doxycycline 200 mg on day 1 followed by 100 mg twice daily may achieve therapeutic levels more rapidly, though this is based on expert opinion rather than trial data. 1

For Outpatients With Comorbidities (COPD, Diabetes, Chronic Heart/Lung/Liver/Renal Disease)

• Combination therapy with amoxicillin-clavulanate 875/125 mg orally twice daily PLUS doxycycline 100 mg twice daily for 5–7 days is the guideline-recommended regimen when macrolides are contraindicated. 1, 2, 3

• Alternative β-lactams include cefpodoxime or cefuroxime (NOT cefixime) combined with doxycycline, though these have inferior pneumococcal activity compared to amoxicillin-clavulanate. 1, 2, 3

• Respiratory fluoroquinolone monotherapy (levofloxacin 750 mg daily or moxifloxacin 400 mg daily) for 5–7 days is an equally effective alternative, though fluoroquinolones should be reserved for patients with contraindications to β-lactams due to FDA warnings about serious adverse events. 1, 2, 3

For Hospitalized Non-ICU Patients

• Ceftriaxone 1–2 g IV daily PLUS doxycycline 100 mg twice daily (IV or oral) is the appropriate regimen when macrolides are contraindicated, providing coverage for typical and atypical pathogens with a conditional recommendation and low-quality evidence. 1, 3

• Respiratory fluoroquinolone monotherapy (levofloxacin 750 mg IV daily or moxifloxacin 400 mg IV daily) is an equally effective alternative with strong recommendation and high-quality evidence. 1, 2, 3

---

Renal Dose Adjustments for Recommended Regimens

Amoxicillin and Amoxicillin-Clavulanate

• No dose adjustment is required for CrCl ≥30 mL/min; for CrCl 10–30 mL/min, reduce to 500 mg every 12 hours; for CrCl <10 mL/min, reduce to 500 mg every 24 hours. 2

Doxycycline

• No dose adjustment is required for any degree of renal impairment, making it an ideal choice for patients with chronic kidney disease. 1, 2

Levofloxacin

• For CrCl 50–80 mL/min, no adjustment is needed; for CrCl 20–49 mL/min, give 750 mg loading dose then 500 mg every 48 hours; for CrCl 10–19 mL/min, give 750 mg loading dose then 500 mg every 48 hours. 2, 3

Moxifloxacin

• No dose adjustment is required for any degree of renal impairment. 2, 3

---

Duration of Therapy

• Treat for a minimum of 5 days AND until the patient is afebrile for 48–72 hours with no more than one sign of clinical instability (temperature ≤37.8°C, heart rate ≤100 bpm, respiratory rate ≤24 breaths/min, systolic BP ≥90 mmHg, oxygen saturation ≥90% on room air, ability to maintain oral intake, normal mental status). 1, 2, 3

• Typical duration for uncomplicated CAP is 5–7 days total. 1, 2, 3

• Extended duration of 14–21 days is required only for specific pathogens: Legionella pneumophila, Staphylococcus aureus, or Gram-negative enteric bacilli. 1, 2, 3

---

Critical Pitfalls to Avoid

• Never use cefixime for pneumonia—it is not guideline-concordant and provides inadequate pneumococcal coverage. 1, 2, 3

• Avoid macrolide monotherapy in areas where pneumococcal macrolide resistance exceeds 25% (most U.S. regions have 20–30% resistance), as this leads to treatment failure and breakthrough bacteremia. 1, 2, 3

• Do not use oral cephalosporins (cefuroxime, cefpodoxime) as first-line agents—they are inferior to high-dose amoxicillin and should only be used when amoxicillin is contraindicated. 1, 2, 3

• If the patient used antibiotics within the past 90 days, select an agent from a different antibiotic class to reduce resistance risk. 1, 2, 3

• Administer the first antibiotic dose immediately upon diagnosis—delayed administration beyond 8 hours increases 30-day mortality by 20–30% in hospitalized patients. 1, 2, 3